Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,992,918 papers from all fields of science
Search
Sign In
Create Free Account
Sum of Longest Diameters
Known as:
SUMLDIAM
, Sum of Longest Diameter
A calculation of the aggregated longest diameter values.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Diameters and sum of longest diameters (SLD) of cutaneous neurofibromas in pregnant and non-pregnant NF1 patients on baseline and follow up examinations.
L. Well
,
A. Jaeger
,
+9 authors
J. Salamon
2020
Corpus ID: 219033559
2017
2017
Abstract 5049: Application of population pharmacokinetic and exposure-response modeling for DS-8201a, a HER2-targeting ADC, predicts 50% ORR in patients with heavily pretreated breast cancer
K. Yoshihara
,
S. Endo
,
K. Tamura
,
T. Doi
,
T. Tokui
2017
Corpus ID: 80433674
Background: Antibody-drug conjugates (ADC) provide a wider therapeutic index by allowing specific targeting of cytotoxic agents…
Expand
Review
2016
Review
2016
Serial pro-gastrin-releasing peptide and neuron specific enolase in predicting radiological response and overall survival of patients with small-cell lung cancer.
A. Ono
,
T. Naito
,
+6 authors
N. Yamamoto
Journal of Clinical Oncology
2016
Corpus ID: 22053631
e22144 Background: Pro-gastrin-releasing peptide (ProGRP: P) and Neuron specific enolase (NSE: N) are specific serological…
Expand
2014
2014
Prognostic value of flare-up phenomenon after discontinuation of sunitinib (SU) or pazopanib (PA) in metastatic renal cell carcinoma (mRCC).
R. Iacovelli
,
F. Massari
,
L. Albiges
,
B. Escudier
2014
Corpus ID: 57871534
448 Background: SU and PA are VEGFR inhibitors, approved for the treatment of mRCC. Cessation of treatment has been reported to…
Expand
2011
2011
Pharmacokinetic and pathophysiologic covariates influencing treatment outcomes with T-DM1 in patients with HER2-positive metastatic breast cancer (MBC).
M. Gupta
,
P. Lorusso
,
+5 authors
S. Girish
Journal of Clinical Oncology
2011
Corpus ID: 44552821
633 Background: T-DM1 is a HER2-directed antibody-drug conjugate (ADC) in development for the treatment of HER2-positive MBC. T…
Expand
2011
2011
Optimization of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
K. Krajewski
,
R. Fougeray
,
+5 authors
J. Bellmunt
Journal of Clinical Oncology
2011
Corpus ID: 25456768
4570 Background: Vinflunine (VFL) has been approved in the European Union for second-line treatment of advanced transitional cell…
Expand
2011
2011
Imaging: A little early tumor shrinkage predicts good outcomes of metastatic RCC
Nick Warde
Nature reviews. Urology
2011
Corpus ID: 39159705
Drugs that target vascular endothelial growth factor (VEGF), such as sunitinib, sorafenib and bevacizumab, are now standard…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE